Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Tuesday, February 21, 2017
CellGenix, a global manufacturer of GMP-grade raw materials for cell therapy, gene therapy and tissue-engineered products, started facility expansions as more customers approach late-stage clinical development and commercialization.
read more
CellGenix GmbH has announced the completion of the second phase of their facility expansion.
read more
CellGenix is pleased to announce the appointment of Daniel Spatz as Vice President Sales, Marketing & Logistics and member of the management team.
read more
Wednesday, February 07, 2018
Golden Meditech announced its associate, Cellenkos successfully registered its stand-alone, manufacturing facility as GMP compliant with FDA.
read more
Wednesday, October 02, 2019
Cellectis and Lonza announced the companies have entered into a manufacturing service agreement covering clinical manufacturing of Cellectis’ allogeneic UCART product candidates targeting hematological malignancies.
read more
Cellectis has entered into a lease agreement to build an 82,000 square foot commercial-scale manufacturing facility named IMPACT in Raleigh, North Carolina.
read more
Wednesday, January 20, 2016
Cellectis, a biopharmaceutical company focused on developing immunotherapies based on gene edited CAR T-cells (UCART), announced that it entered into a new agreement for the cGMP manufacturing of UCART123 clinical batches, Cellectis’ lead product ...
read more
Tuesday, October 10, 2017
Protea Biosciences announced it plans to develop clinical screening assays in various areas of oncology.
read more
CellCarta and Olink Proteomics AB announced a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies.
read more
CellCarta announced the appointment of Ehab A. El-Gabry, MD, as Chief Medical Officer and Head of Companion Diagnostics. In this role, Dr. El-Gabry will provide medical and scientific leadership across CellCarta's biomarker programs and lead the ...
read more
CellCarta, a global provider of precision medicine services, has announced the acquisition of Reveal Biosciences.
read more
Tuesday, December 14, 2021
CellCarta, a global provider of precision medicine laboratory services, announced the acquisition of Biogazelle ("Biogazelle"), a leader in genomic testing solutions. Located in Ghent (Belgium), Biogazelle develops and deploys high-end digital PCR (...
read more
Cellbox Solutions is pleased to announce the opening of its new headquarters in Norderstedt, which is located nearby Hamburg, Germany.
read more
Cellaria announced a new sales and marketing agreement with Biological Industries to promote custom stem cell services.
read more
Cellaria, LLC has announced the expansion of its offerings to include a suite of stem cell services. The initiative advances Cellaria’s mission to provide more accurate patient and disease-specific cell models to help researchers focus and accelerate...
read more